Sandoz, F. Hoffman La-Roche settle patent dispute over biosimilar
Healthcare 2019-04-09 10:01 pm By Cat Fredeburgh | Melbourne
Please login to bookmark Close

F. Hoffman La-Roche has reached a settlement in a patent lawsuit over Sandoz’s plan to market a biosimilar version of its patented biologic used to treat various cancers and rheumatoid arthritis.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au